Overview of benzene-induced aplastic anaemia

European Journal of Haematology, Supplement

Volumn 57, Issue 60, 1996, Pages 107-110

  Smith, Martyn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Benzene; Biomarkers; Genetic susceptibility; Haematoxicity; Risk assessment

Indexed keywords

BENZENE; CYTOCHROME P450;

APLASTIC ANEMIA; CONFERENCE PAPER; METABOLITE; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DOSE RESPONSE; HUMAN; OCCUPATIONAL EXPOSURE; REVIEW;

ANEMIA, APLASTIC; BENZENE; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; OCCUPATIONAL EXPOSURE;

EID: 0030338602     PISSN: 09024506     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (48)

1. SANTESSON CG. Über chronische Vergiftung mit Steinkohlenteerbenzin: vier Todesfälle. Arch Hyg Berl 1897: 31: 336-376.
2. LE NOIRE MM, CLAUDE H. Sur un case de purpura attribué à l'intoxication par le benzene. Bull Mem Soc Med Hop Paris 1897: 3: 1251.
3. SELLING L. Benzol, a leucotoxine. Study on the degeneration of the blood and hematopoietic organs. Johns Hopkins Hosp Rep 1916: 17: 83-142.
4. WEISKOTTEN HG, SHWARTZ SC, STEINSLAND HS. The action of benzol on blood and blood forming tissues. J Med Res 1916: 35: 63-69.
5. WEISKOTTEN HG, GIBBS GBF, BOGGS EO, TEMPLETON ER. The action of benzol. VI. Benzol vapor leucopenia (rabbit). J Med Res 1920: 41: 425-438.
6. KORANYI BA. 17th Int Congr Med, part 2(6), London. Oxford: Oxford University Press, 1913.
7. ROCHNER FJ, BOLDRIGE CW, HAUSMANN GH. Chronic benzol poisoning. Proc Soc Exp Biol Med 1925: 33: 323.
8. HAMILTON A. The growing menace of benzene (benzol) poisoning in American industry. JAMA 1922: 78: 627-630.
9. GREENBERG L, MAYERS MR, GOLDWATER L, SMITH AR. Benzene (benzol) poisoning in the rotogravure printing industry in New York City. J Ind Hyg Toxicol 1939: 23: 395-420.
10. GOLDWATER LJ. Disturbances in the blood following exposure to benzol. J Lab Clin Med 1942: 26: 957-973.
11. WILSON RH. Benzene poisoning in industry. J Lab Clin Med 1942: 27: 1517-1521.
12. SAVILAHTI M. Mehr als 100 Vergiftungsfälle durch benzol in einer schuh fabrik. Arch Gewerbepathol Gewerbehyg 1956: 15: 147-157.
13. HERNBERG S, SAVILAHTI S, AHLMAN K, ASP S. Prognostic aspects of benzene poisoning. Br J Ind Med 1966: 23: 204-209.
14. HIROKOWA MT. Some observations on chronic benzene intoxication. Arch Mal Prof Hyg Toxicol Ind 1960: 21: 46-49.
15. LOB M. Etiological role of benzene in 2 supposedly cryptogenetic fatal hemopathies. Schweiz Med Wochenschr 1969: 99: 1188-1189.
16. FORNI A, VIGLIANI EC. Chemical leukemogenesis in man. Ser Haematol 1974: 7: 211-223.
17. VIGLIANI EC, FORNI A. Benzene and leukemia. Environ Res 1976: 11: 122-127.
18. AKSOY M. Benzene carcinogenicity. In: AKSOY M, ed. Benzene Carcinogenicity. Boca Raton, Florida: CRC Press Inc, 1988: 113-151.
19. AKSOY M, DINCOL K, AKGUN T, ERDEM S, DINCOL G. Haematological effects of chronic benzene poisoning in 217 workers. Br J Ind Med 1971: 28: 296-302.
20. AKSOY M, OZERIS S, SABUNCU H, INANICI Y, YANARDAG R. Exposure to benzene in Turkey between 1983 and 1985: a haematological study on 231 workers. Br J Ind Med 1987: 44: 785-787.
21. YIN SN, Li Q, LIU Y, TIAN F, DU C, JIN C. Occupational exposure to benzene in China. Br J Ind Med 1987: 44: 192-195.
22. YIN SN, LI GL, TAIN FD, et al. A retrospective cohort study of leukemia and other cancers in benzene workers. Environ Health Perspect 1989: 82: 207-213.
23. YIN SN, LI GL, LIU Y, JIN C. A survey of benzene aplastic anemia in a shoemaking factory. Science and Technology of Labour Protection (in Chinese) 1986: 960: 14-17.
24. GOLDSTEIN BD. Benzene toxicity: a critical evaluation: hematotoxicity in humans. J Toxicol Environ Health Suppl 1977: 2: 69-105.
25. GOLDSTEIN BD. Clinical hematotoxicity of benzene. Advances in Modern Environmental Toxicology, vol. 16. Benzene: occupational and environmental hazards scientific update. Princeton: Princeton Scientific Publishing, 1989: 55-65.
26. MARCUS WL. Chemical of current interest-benzene. Toxicol Ind Health 1987: 3: 205-266.
27. GOLDSTEIN BD. Clinical hematotoxicity of benzene. In: MEHLMAN MA, ed. Advances in Modern Environmental Toxicology: Carcinogenicity and Toxicity of Benzene, Vol. 4. Princeton: Princeton Scientific Publishers, 1983: 51-61.
28. BASLO A, AKSOY M. Neurological abnormalities in chronic benzene poisoning. A study of six patients with aplastic anemia and two with preleukemia. Environ Res 1982: 27: 457-465.
29. AKSOY M. Malignancies due to occupational exposure to benzene. Am J Ind Med 1985: 7: 395-402.
30. ROTHMAN N, CAMPLEMAN S, HAYES RB, et al. High CYP2E1 activity is a risk factor for benzene poisoning. Proc Am Assoc Cancer Res (abstract 1679) 1995: 36: 282.
31. ROTHMAN N, SMITH MT, HAYES RB, et al. An epidemiologic study of benzene's early biologic effects among heavily exposed workers in Shanghai, China. Environ Health Perspect 1996 (in press).
32. YIN SY, HAYES RB, LINET MS, et al. A cohort study of cancer among benzene-exposed workers in China: Overall results. Am J Ind Med 1996: 29: 227-235.
33. BAARSON KA, SNYDER CA, ALBERT RE. Repeated exposure of C57B1 mice to inhaled benzene at 10 p.p.m. markedly depressed erythropoietic colony formation. Toxicol Lett 1984: 20: 337-342.
34. WARD E, HORNUNG R, MORRIS J, et al. Risk of low red or white blood cell count related to estimated benzene exposure in a rubberworker cohort (1940-1975). Benzene'95: International Conference on the Toxicity, Carcinogenesis, and Epidemiology of Benzene. Rutgers University, New Jersey, 1995.
35. KALF GF. Recent advances in the metabolism and toxicity of benzene. Crit Rev Toxicol 1987: 18: 141-159.
36. YARDLEY-JONES A, ANDERSON D, PARKE DV. The toxicity of benzene and its metabolism and molecular pathology in human risk assessment. Br J Ind Med 1991: 48: 437-444.
37. EASTMOND DA, SMITH MT, IRONS RD. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol 1987: 91: 85-95.
38. SMITH MT, YAGER JW, STEINMETZ KM, EASTMOND DA. Peroxidasedependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ Health Perspect 1989: 82: 23-29.
39. IRONS RD. Quinones as toxic metabolites of benzene. J Toxicol Environ Health 1985: 16: 673-678.
40. SUBRAHMANYAM VV, ROSS D, EASTMOND DA, SMITH MT. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Rad Biol Med 1991: 11: 495-515.
41. SCHATTENBERG DG, STILLMAN WS, GRUNTMEIR JJ, HELM KM, IRONS RD, ROSS D. Peroxidase activity in murine and human hematopoietic progenitor cells: potential relevance to benzene-induced toxicity. Mol Pharmacol 1994: 46: 346-351.
42. IRONS RD, STILLMAN WS, COLAGIOVANNI DB, HENRY VA. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro. Proc Natl Acad Sci USA 1992: 89: 3691-3695.
43. WHITE WC, GAMMON AM. The influence of benzol inhalation on experimental pulmonary tuberculosis in rabbits. Trans Assoc Amer Phys 1914: 29: 332-337.
44. WINTERNITZ MC, HIRSCHFELDER AD. Studies upon experimental pneumonia in rabbits: Parts IIII. J Exptl Med 1913: 17: 657-664.
45. SIMONDS JP, JONES HM. The effect of injections of benzol upon the production of antibodies. J Med Res 1915: 33: 197-209.
46. IRONS RD, WIERDA D, PFEIFER RW. Immunotoxicity of benzene and its metabolites. Adv Mod Environ Toxicol 1983: 4: 37-50.
47. LANGE A, SMOLIK R, ZATONSKI W, SZYMANSKA J. Serum immunoglobulin levels in workers exposed to benzene, toluene and xylene. Int Arch Arbeitsmed 1973: 31: 37-44.
48. SMOLIK R, GRZYBEK-HRYNCEWICZ K, LANGE A, ZATONSKI W. Serum complement level in workers exposed to benzene, toluene and xylene. Int Arch Arbeitsmed 1973: 31: 243-247.